# Carsten Bokemeyer

Source: https://onco.cc/people/carsten-bokemeyer/  
OnCo record `carsten-bokemeyer` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Medical oncologist known for germ cell tumour research and anti-EGFR trials in colorectal cancer.

## Summary

Carsten Bokemeyer is Director of the Department of Oncology, Hematology and BMT at Universitätsklinikum Hamburg-Eppendorf. A medical oncologist, his specialisms are testicular cancer, colorectal cancer and medical oncology. He led the OPUS trial of cetuximab with FOLFOX in colorectal cancer and has a long record in germ cell tumour research. His papers include a study of early tumour shrinkage as a predictor of long-term outcome in cetuximab-treated metastatic colorectal cancer, a European Urology report establishing serum microRNA miR-371a-3p as a biomarker for germ cell tumours, and a review of catumaxomab, a trifunctional anti-EpCAM antibody used for malignant ascites. His publications are listed on PubMed.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Director, Department of Oncology, Hematology and BMT, UKE Hamburg
- Specialisms: Testicular cancer; Colorectal cancer; Medical oncology

## Sources

- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Bokemeyer%20C%5BAuthor%5D%20cetuximab%20colorectal

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/)
- drugs: [Cetuximab](https://onco.cc/drugs/cetuximab/)
- institutions: [Universitätsklinikum Hamburg-Eppendorf](https://onco.cc/institutions/uke-hamburg/)

---
JSON: https://onco.cc/api/v1/entities/carsten-bokemeyer.json